Apogem Capital LLC Morphic Holding, Inc. Transaction History

Apogem Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $198,396 - $284,705	-5,473 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $4,024 - $6,111	93 Added 1.73%	5,473 $259,000
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $23,534 - $29,632	439 Added 8.88%	5,380 $305,000
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $222,987 - $321,115	4,941 New	4,941 $284,000

140

38.7M

4.2K

200K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.